As of Dec 15
| 0.00 / 0.00%|
The 8 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 154.00, with a high estimate of 207.99 and a low estimate of 61.00. The median estimate represents a +18.27% increase from the last price of 130.21.
The current consensus among 8 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.